May Measurement Month 2018–2019: an analysis of blood pressure screening results from Austria . (7th October 2022)

• Record Type: Journal Article
• Authors: Glantschnig, Theresa; Koppelstätter, Christian; Zweiker, David; Kolesnik, Ewald; Niederl, Ella; Kraler, Elisabeth; Stoff, Ingrid; Zweiker, Robert; Weber, Thomas; Horn, Sabine; Weiss, Thomas; Wang, Wei; Beaney, Thomas; Poulter, Neil R; Perl, Sabine
• Is Part Of: European heart journal supplements. Volume 24(2022)Supplement F
• Page Start: F6
• Page End: F8
• Publication Date: 2022-10-07
• Subjects: Hypertension -- Blood Pressure -- Screening -- Treatment -- Control; Cardiology -- Periodicals; Cardiology -- Europe -- Periodicals; 616.12005
• DOI: 10.1093/eurheartjsupp/suac038
• Languages: English
• ISSNs: 1520-765X

Abstract

Abstract: Arterial hypertension is a global burden leading to over 10.8 million deaths per year worldwide. May Measurement Month (MMM) is a global project initiated by the International Society of Hypertension to raise the awareness of high blood pressure (BP) in the population. Following the MMM protocol 2508 participants ≥18 years had their BP measured in Austria in MMM18 and MMM19. Of those screened, 54.6% were found to be hypertensive, defined as a BP ≥140/90 mmHg and/or being on treatment for hypertension. Among those individuals with hypertension, 56.1% were on medication but only 42.0% of those treated had controlled BP (<140/90 mmHg). Lower BPs were found in those with previous myocardial infarction (MI), probably explained by a medical monitoring system of patients with MI in Austria. Those with hypertension were referred for further medical investigations and were provided lifestyle advice. Among a high number of individuals receiving antihypertensive treatment, BP is still not controlled. Further screening and monitoring of therapeutic effects is urgently required.